Document ID: chunk:federal_register_of_legislation:F2020L00214:reg:9:p2
Version: federal_register_of_legislation:F2020L00214
Segment Type: reg
Provision Reference: reg 9 (pt 2/2)
Character Range: 6795–9042

the clinical worsening of multiple sclerosis;
(11)      undergoing a course of treatment with an immune checkpoint inhibitor within the four months before the clinical worsening of multiple sclerosis;
            Note: Immune checkpoint inhibitors include, but are not limited to, ipilimumab, nivolumab, atezolizumab and pembrolizumab.
(12)      experiencing the death of a significant other within the three months before the clinical worsening of multiple sclerosis;
            Note: significant other is defined in the Schedule 1 - Dictionary.
(13)      experiencing a category 1A stressor within the three months before the clinical worsening of multiple sclerosis;
            Note: category 1A stressor is defined in the Schedule 1 - Dictionary.
(14)      experiencing a category 1B stressor within the three months before the clinical worsening of multiple sclerosis;
            Note: category 1B stressor is defined in the Schedule 1 - Dictionary.
(15)      experiencing a category 2 stressor within the three months before the clinical worsening of multiple sclerosis;
             Note 1:  A category 2 stressor can arise in a variety of circumstances connected with service.  Such circumstances can arise during the course of service, as a result of separation from service and the conditions associated with that separation, and in the transition to civilian life in the years following separation.
            Note 2:  category 2 stressor is defined in the Schedule 1 - Dictionary.
(16)      having a medical illness or injury, other than multiple sclerosis, which is life-threatening or which results in serious physical or cognitive disability, within the three months before the clinical worsening of multiple sclerosis;
(17)      for women only, using hormonal assisted reproductive therapy within the three months before the clinical worsening of multiple sclerosis;
            Note: hormonal assisted reproductive therapy is defined in the Schedule 1 - Dictionary.
(18)      undergoing a course of therapeutic radiation for cancer, where the affected site was in the field of radiation, before the clinical worsening of multiple sclerosis;
(19)      inability to obtain appropriate clinical management for multiple sclerosis.